Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma.
Basu R, Kulkarni P, Qian Y, Walsh C, Arora P, Davis E, Duran-Ortiz S, Funk K, Ibarra D, Kruse C, Mathes S, McHugh T, Brittain A, Berryman DE, List EO, Okada S, Kopchick JJ. Basu R, et al. Among authors: davis e. Cancers (Basel). 2019 Sep 12;11(9):1352. doi: 10.3390/cancers11091352. Cancers (Basel). 2019. PMID: 31547367 Free PMC article.
Mice with gene alterations in the GH and IGF family.
Qian Y, Berryman DE, Basu R, List EO, Okada S, Young JA, Jensen EA, Bell SRC, Kulkarni P, Duran-Ortiz S, Mora-Criollo P, Mathes SC, Brittain AL, Buchman M, Davis E, Funk KR, Bogart J, Ibarra D, Mendez-Gibson I, Slyby J, Terry J, Kopchick JJ. Qian Y, et al. Among authors: davis e. Pituitary. 2022 Feb;25(1):1-51. doi: 10.1007/s11102-021-01191-y. Epub 2021 Nov 19. Pituitary. 2022. PMID: 34797529 Free PMC article. Review.
Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma in vivo.
Basu R, Qian Y, Mathes S, Terry J, Arnett N, Riddell T, Stevens A, Funk K, Bell S, Bokal Z, Batten C, Smith C, Mendez-Gibson I, Duran-Ortiz S, Lach G, Mora-Criollo PA, Kulkarni P, Davis E, Teaford E, Berryman DE, List EO, Neggers S, Kopchick JJ. Basu R, et al. Among authors: davis e. Front Oncol. 2022 Jul 5;12:936145. doi: 10.3389/fonc.2022.936145. eCollection 2022. Front Oncol. 2022. PMID: 35865483 Free PMC article.
Growth hormone receptor gene disruption.
List EO, Duran-Ortiz S, Kulkarni P, Davis E, Mora-Criollo P, Berryman DE, Kopchick JJ. List EO, et al. Among authors: davis e. Vitam Horm. 2023;123:109-149. doi: 10.1016/bs.vh.2022.12.004. Epub 2023 Aug 24. Vitam Horm. 2023. PMID: 37717983
2023 MHC Awards and Recognition.
VandenBerg A, Davis EAK. VandenBerg A, et al. Among authors: davis eak. Ment Health Clin. 2024 Apr 1;14(2):79-81. doi: 10.9740/mhc.2024.04.079. eCollection 2024 Apr. Ment Health Clin. 2024. PMID: 38694884 Free PMC article. No abstract available.
Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement.
US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, Barry MJ, Chelmow D, Coker TR, Davis EM, Jaén CR, Krousel-Wood M, Lee S, Li L, Mangione CM, Rao G, Ruiz JM, Stevermer JJ, Tsevat J, Underwood SM, Wiehe S. US Preventive Services Task Force, et al. Among authors: davis em. JAMA. 2024 Apr 30. doi: 10.1001/jama.2024.5534. Online ahead of print. JAMA. 2024. PMID: 38687503
3,528 results